Anand Rathi keeps INR 1,220.00 target for Max Health stock

Published on 10/14/2026 at 09:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q1 FY27 revenue rose 15.2 percent to INR 28.35 billion. Max Health stock costs INR 862.60 on October 14, 2026, up 0.19 percent on NSE.

Analyst target and price position

Anand Rathi Research retained a INR 1,220.00 target for Max Health on August 17, 2026, 41.43 percent above the price.
Revenue rose 15.2 percent to INR 28.35 billion in the first quarter of fiscal 2027.
Max Health stock costs INR 862.60 on NSE on October 14, 2026 at 12:49 p.m. IST, up 0.19 percent versus the previous close of INR 861.00.
Max Health's price-to-earnings ratio was 57.84 and its market capitalization was INR 839.5 billion on October 14, 2026.

Max Health, INE027H01010, Illustration mit AI erstellt.

Anand Rathi Research retained its INR 1,220.00 target and Buy recommendation for Max Health on August 17, 2026. At the NSE price of INR 862.60 on October 14, 2026 at 12:49 p.m. IST, that target stood 41.43 percent above the stock. Max Health stock was up 0.19 percent from the previous close of INR 861.00.

Revenue rises in fiscal 2027

DSIJ reported that consolidated revenue increased 15.2 percent year over year to INR 28.35 billion in the first quarter of fiscal 2027. The figure was 4.30 percent above the broker estimate of INR 27.19 billion, giving the growth story a measurable earnings base.

The same August 17, 2026 update said Anand Rathi lifted its fiscal 2027 and fiscal 2028 estimates modestly, while retaining the INR 1,220.00 target. The target implies a 41.43 percent gap above the October 14 price, a wider spread than the daily move of 0.19 percent.

Price sits 29.41 percent below high

At INR 862.60, Max Health was 29.41 percent below its 52-week high of INR 1,221.90 and 2.44 percent above its 52-week low of INR 842.05 on October 14, 2026. Trading volume was 1,489,167 shares against an average volume of 2,242,368 shares, while market capitalization stood at INR 839.5 billion.

Max Healthcare's investor page describes a network of 21 healthcare facilities with more than 6,100 beds, alongside MAX@Home and MaxLab businesses. The company is led by Chairman and Managing Director Abhay Soi, according to Max Healthcare.

Valuation and the next date

The price-to-earnings ratio was 57.84 on October 14, 2026, while the trailing dividend yield was 0.00 percent. The next quarterly results date is November 20, 2026, according to TickerLandia.

Comparison with peers

Max Health (NSE, INR): plus 0.19 percent, P/E 57.83, market capitalization INR 839.2 billion.
Apollo Hospitals (NSE, INR): minus 0.33 percent, P/E 53.99, market capitalization INR 1,128.0 billion.
Fortis Healthcare (NSE, INR): minus 1.14 percent, P/E 53.86, market capitalization INR 564.5 billion.

Trading level and valuation

Max Health's INR 862.60 NSE price on October 14, 2026 at 12:49 p.m. IST places the stock near its 52-week low, while the Anand Rathi target remains materially higher at INR 1,220.00. The next test for the operating story is the November 20, 2026 quarterly reporting date.